Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP19A1 | P11511 | 7/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HLCS | P50747 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.30 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11125187 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL11125192 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL14822502 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL3269617 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL39157 | 1.00 | ALDH1A1 (0.35) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| Ammonia Solution, Strong SCHEMBL4243822 | 0.99 | ALDH1A1 (0.35) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL13779814 | 0.96 | MAPK1 (0.38) | ALDH1A1MAPK1CYP19A1LMNAMEN1 | |
| SCHEMBL28833723 | 0.94 | LMNA (0.33) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL6050499 | 0.93 | MAPK1 (0.32) | ALDH1A1MAPK1L3MBTL1CYP19A1LMNA | |
| SCHEMBL13588314 | 0.89 | MAPK1 (0.38) | ALDH1A1MAPK1LMNAMCOLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080220031-A1 | Dermocosmetic Preparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | claimed |
| US-20130085186-A1 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS | BASF SE (DE) | 2013-04-04 | — | — | US | disclosed |
| US-20100048737-A1 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS | BASF SE (DE) | 2010-02-25 | — | — | US | disclosed |
| US-20090156485-A1 | METHOD FOR COUPLING KERATIN-BINDING POLYPEPTIDES WITH EFFECTOR MOLECULES WHICH SUPPORT CARBOXYLIC GROUPS OR SULFONIC ACID GROUPS | BASE SE (DE) | 2009-06-18 | — | — | US | disclosed |
| US-20090098076-A1 | Method For the Production of a Keratin-Binding Effector Molecule | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090099075-A1 | Chimeric Keratin-Binding Effector Proteins | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20080220031-A1 | Dermocosmetic Preparations | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085186-A1 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS | PRDM7, FABP4, PLIN1 | ALDH1A1 166/4885MAPK1 2710/4885L3MBTL1 3612/4885 |
| US-20090156485-A1 | METHOD FOR COUPLING KERATIN-BINDING POLYPEPTIDES WITH EFFECTOR MOLECULES WHICH SUPPORT CARBOXYLIC GROUPS OR SULFONIC ACID GROUPS | KRT18, KRTCAP2, CUTA | ALDH1A1 3455/4885MAPK1 3549/4885L3MBTL1 4411/4885 |
| US-20100048737-A1 | COSMETIC PREPARATIONS BASED ON MOLECULARLY IMPRINTED POLYMERS | PRDM7, FABP4, PLIN1 | ALDH1A1 166/4885MAPK1 2710/4885L3MBTL1 3612/4885 |
| US-20080220031-A1 | Dermocosmetic Preparations | C3AR1, C1S, C1R | ALDH1A1 1951/4885MAPK1 2373/4885L3MBTL1 976/4885 |
| US-20090099075-A1 | Chimeric Keratin-Binding Effector Proteins | KRT18, KRTCAP2, CKAP4 | ALDH1A1 4225/4885MAPK1 3625/4885L3MBTL1 1390/4885 |
| US-20090098076-A1 | Method For the Production of a Keratin-Binding Effector Molecule | KRT18, KRTCAP2, CUTA | ALDH1A1 3750/4885MAPK1 3547/4885L3MBTL1 3908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.